Marshall Wace North America »

Royalty Pharma shares owned by Marshall Wace North America

Quarter-by-quarter ownership of Royalty Pharma (RPRX) shares owned by Marshall Wace North America from 13F filings

Historical chart of Marshall Wace North America investment in Royalty Pharma

Tip: Access up to 7 years of quarterly data

All positions including Royalty Pharma held by Marshall Wace North America consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Royalty Pharma by Marshall Wace North America

Quarter filed Position value Share count Share price at filing
2021-09-30 $26M 732k 36.14
2020-09-30 $7.1M 169k 42.07
2020-06-30 $2.8M 57k 48.55

More positions owned by Marshall Wace North America

Amazon.com Common Stock (AMZN)
Microsoft Corp Common Stock (MSFT)
Alphabet Inc-c Common Stock (GOOG)
Alphabet Inc-a Common Stock (GOOGL)
Meta Platforms-a Common Stock (META)
Thermo Fisher Common Stock (TMO)
Apple Common Stock (AAPL)
Zoetis Common Stock (ZTS)
Netflix Common Stock (NFLX)
Uber Technologie Common Stock (UBER)
Boston Scientifc Common Stock (BSX)
Adobe Common Stock (ADBE)
Expedia Group In Common Stock (EXPE)
Steris Common Stock (STE)
Unitedhealth Grp Common Stock (UNH)

View all positions for Marshall Wace North America

Top funds holding Royalty Pharma

Vanguard Group
Baillie Gifford & Co
Viking Global Investors
Jpmorgan Chase & Co
Unisphere Establishment
Norges Bank Investment Management
Amundi
Siguler Guff Advisers
Legal & General Group
Goldman Sachs Group
Man Group
CalPERS
Two Sigma Investments
Two Sigma Advisers
Henderson Group

View all funds holding Royalty Pharma